Long-lasting radionuclide therapy for advanced metastatic neuroendocrine tumors (NETs) appear to prove effective. The new therapy, Lu-DOTA-EB-TATE is a three-in-one therapeutic compound, with an octreotate peptide to find the tumor.
from Medindia Health News https://ift.tt/2tB97Mg
No comments:
Post a Comment